EVRAZ plc Announces That the Appointment and the Amendments Adopted as Part of the Consent Solicitation for Its Outstanding $700,000,000 5.250% Notes Due 2024 Become Effective

EVRAZ plc (the Issuer) announced consent solicitation in relation to the outstanding $700,000,000 5.250% notes due 2024 issued by the Issuer (Regulation S Notes: Common Coder 184344327 /ISIN XS1843443273; Rule 144A Notes: Common Code 111730776 /ISIN US30052KAA79/CUSIP 30052KAA7) (the Notes) on the terms and subject to the conditions set forth in the consent solicitation memorandum dated 15 November 2022 (the Consent Solicitation Memorandum). Capitalised terms used, but not defined herein, shall have the meanings given to them in the Consent Solicitation Memorandum. The Issuer notifies that, on 23 December 2022, (i) the Issuer and the New Trustee entered into the Deed of Appointment to effectuate the Appointment; and (ii) the Issuer and the New Trustee entered into the Supplemental Trust Deed to effectuate the Amendments.

Accordingly, the Appointment and the Amendments have become effective and binding on all Noteholders with effect from that date.